Alliance Boots Doubles Down In China With 12% Stake Of Nanjing Pharma
This article was originally published in PharmAsia News
Executive Summary
As MNCs increase stakes in China’s pharmaceutical distribution market, the highly segmented nature of the industry will remain a challenge for market penetration, analysts say.
You may also be interested in...
Alliance Boots Taps Retired Zuellig Pharma CEO to Lead Asia Operation, With M&A On The Mind
Major UK pharmaceutical and beauty products distributor Alliance Boots announced the appointment of retired Zuellig Pharma CEO Fritz Horlacher to head its heathcare division in Asia. The company aims to expand in Asia, especially in Thailand and Korea, which will pose a big challenge to Zuellig and other heavyweight pharmaceutical distributors
Cardinal Eyeing Further Acquisitions In China
Cardinal Health's recent acquisition of Zuellig Pharma China (Yong Yu in Chinese) likely will not be the last China-based distributor the U.S. wholesaler will pick up, according to company CFO Jeff Henderson
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.